Skip to main content
. 2018 Apr 13;6(7):1000–1006. doi: 10.1177/2050640618770013

Table 1.

Demographic, clinical, endoscopic and histological breakdown of all patients within study cohort.

Cohort variables
Age Median 75 (IQR 60–82)
Sex
 Male 59 (53.2%)
 Female 52 (46.8%)
Smoking status
 Never 34 (30.6%)
 Current 26 (23.4%)
 Ex smoker 16 (14.4%)
 Data missing 36 (31.5%)
Ethnicity
 Caucasian 107 (96.4%)
 Indian 2 (1.8%)
 Arab 1 (0.9%)
 Data missing 1 (0.9%)
Charlson Comorbidity Index Score Median 5 (IQR 4–6)
Indications for endoscopy
 Dyspepsia 10 (9.0%)
 Upper GI bleed 61 (55.0%)
 Fe deficiency anaemia 21 (18.9%)
 Weight loss 7 (6.3%)
 Abdominal pain 1 (0.9%)
 Vomiting/nausea 6 (5.4%)
 Other 2 (1.8%)
No. of ulcers per index oesophago-gastroduodenoscopy (OGD) Median 1.0 (Range 1–7)
Size of gastric ulcer (cm) Median 4.0 (IQR 3–5)
Endoscopic appearance
 Superficial 16 (14.4%)
 Linear 2 (1.8%)
 Cratered 92 (82.9%)
 Superficial/linear 1 (0.9%)
Ulcer location
 Cardia/Fundus 6 (5.2%)
 Body 59 (50.9%)
 Incisura 8 (6.9%)
 Antrum/pre-pyloric 43 (37.1%)
Endoscopist's suspicion
 Non-suspicious 38 (34.2%)
 Suspicious 65 (58.6%)
 Data missing 8 (7.2%)
H. pylori status
 Negative 55 (49.5%)
 Positive 26 (23.4%)
 Not tested 30 (27.0%)
Histological diagnosis
 Benign 69 (62.2%)
 Adenocarcinoma 34 (30.6%)
 Lymphoma 6 (5.4%)
 Other neoplasia 2 (1.8%)
  - Pancreatic head adenocarcinoma  - Neuroendocrine tumour